St. David's Office of Research

Main Navigation



St. David’s Medical Center Enrolls in Two COVID-19 Studies

AUSTIN, Texas—St. David’s Medical Center is testing two promising COVID-19 therapies in clinical trials. The medications being tested are lenzilumab and ruxolitinib, both of which focus on inflammatory pathways in […]

St. David’s NICU Enrolls in Probiotics Study

AUSTIN, Texas—St. David’s Medical Center Neonatal Intensive Care Unit (NICU) is participating in a clinical trial on necrotizing enterocolitis (NEC).  NEC is a severe inflammatory disease of the gastrointestinal systems […]

St. David’s HealthCare Advances COVID-19 Clinical Research

AUSTIN, Texas—St. David’s HealthCare through the Office of Research is participating in multiple Phase III clinical trials on COVID-19, particularly those studying treatments on patients with severe to life threatening […]